Lite Version|Standard version

RSC Pharmaceutics

Recent Articles
Per Pg:
Pg 1 of 5
Reversibility of FUS-aided blood–tumor barrier opening for the delivery of therapeutics
Céline Chevaleyre, Sophie Tran, Mylène Richard, Laurène Jourdain, Dimitri Kereselidze, Benoit Jego, Erwan Selingue, Benoit Larrat, Sébastien Mériaux, Nicolas Tournier, Anthony Novell and Charles Truillet
RSC Pharm., 2025, Advance Article

DOI: 10.1039/D5PM00088B, Communication
Published: 01 Aug 2025
Unlocking the potential of exosomes ‘extracellular vesicles’: drug delivery advancements and therapeutics in ocular diseases
Nagendra Verma, Swati Arora, Anurag Kumar Singh and Jahangir Ahmed
RSC Pharm., 2025, Accepted Manuscript

DOI: 10.1039/D5PM00097A, Review Article
Published: 07 Aug 2025
The potential of small extracellular vesicles for pancreatic cancer therapy
Richard Crow, Oksana Kehoe and Clare Hoskins
RSC Pharm., 2025, Accepted Manuscript

DOI: 10.1039/D5PM00115C, Review Article
Published: 06 Aug 2025
Mitigating oxidative stress in red blood cells with quercetin-loaded liposomes: a promising strategy
Akshay Kumar, Stuti Bhagat, Kareena Moar, Sanjay Singh and Pawan Kumar Maurya
RSC Pharm., 2025, Advance Article

DOI: 10.1039/D5PM00112A, Paper
Published: 05 Aug 2025
Emerging drug delivery strategies for glaucoma therapy: Focus on nanoparticles and stimuli responsive systems
Sourabh Kundu, Gitika Kumari and Dadi A Srinivasarao
RSC Pharm., 2025, Accepted Manuscript

DOI: 10.1039/D5PM00068H, Review Article
Published: 05 Aug 2025
Per Pg:
Pg 1 of 5
Page: ^ Top